Aterovax Overview

  • Founded
  • 2006
  • Status
  • Out of Business
  • Employees
  • 5
  • Latest Deal Type
  • Out of Business

Aterovax General Information


Developer of diagnostic products for the treatment of atherosclerosis. The company develops diagnostic tests for cardiovascular risk prediction by assessing the level of patients' atherosclerosis plaque development.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Diagnostic Equipment
Medical Supplies
Primary Office
  • Pepiniere paris Sante Cochin
  • 29 rue du Faubourg Saint-Jacques
  • 75014 Paris
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aterovax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Apr-2016 00.000 Completed Out of Business
3. Later Stage VC 12-May-2013 00.000 00.000 Completed Generating Revenue
2. Grant 26-Jul-2008 $2.29M $3.8M Completed Startup
1. Seed Round 01-Jul-2006 $3.8M $3.8M Completed Startup
To view Aterovax’s complete valuation and funding history, request access »

Aterovax Executive Team (8)

Name Title Board Seat Contact Info
Gerald Ulrich Ph.D Chief Operative Officer
Emmanuel Valentin Ph.D Head & Director, Research & Development
You’re viewing 2 of 8 executive team members. Get the full list »

Aterovax Board Members (3)

Name Representing Role Since
Antoine Ferry MD Self Board Member 000 0000
Eric Viaud Self Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Aterovax Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial